<i>miR-29</i> modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitorsSonali Sharma, Marek Mráz, Eva Vojáčková et al.|Blood|2021Cited by 63
IL4-STAT6 signaling induces CD20 in chronic lymphocytic leukemia and this axis is repressed by PI3Kδ inhibitor idelalisibVeronika Šandová, Marek Mráz, Gabriela Mladonická Pavlasová et al.|Haematologica|2021Cited by 22